Clinical Trial Update: To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating thrice-weekly vadadustat versus standard of care ESAs for anemia of chronic kidney disease in patients on in-center hemodialysis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• Vadadustat (vadadustat)

Snippet

Sponsor: Akebia Therapeutics | Conditions: Anemia of Chronic Kidney Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING